Age-dependent lethality in novel transgenic mouse models of central nervous system arteriovenous malformations
- PMID: 22328553
- DOI: 10.1161/STROKEAHA.111.647024
Age-dependent lethality in novel transgenic mouse models of central nervous system arteriovenous malformations
Abstract
Background and purpose: The lack of an appropriate animal model has been a limitation in studying hemorrhage from arteriovenous malformations (AVMs) in the central nervous system.
Methods: Novel mouse central nervous system AVM models were generated by conditionally deleting the activin receptor-like kinase (Alk1; Acvrl1) gene with the SM22-Cre transgene. All mice developed AVMs in their brain and/or spinal cord, and >80% of them showed a paralysis or lethality phenotype due to internal hemorrhages during the first 10 to 15 weeks of life. The mice that survived this early lethal period, however, showed significantly reduced lethality rates even though they carried multiple AVMs.
Results: The age-dependent change in hemorrhage rates allowed us to identify molecular factors uniquely upregulated in the rupture-prone AVM lesions.
Conclusions: Upregulation of angiopoietin 2 and a few inflammatory genes were identified in the hemorrhage-prone lesions, which may be comparable with human pathology. These models will be an exceptional tool to study pathophysiology of AVM hemorrhage.
Similar articles
-
Thalidomide Reduces Hemorrhage of Brain Arteriovenous Malformations in a Mouse Model.Stroke. 2018 May;49(5):1232-1240. doi: 10.1161/STROKEAHA.117.020356. Epub 2018 Mar 28. Stroke. 2018. PMID: 29593101 Free PMC article.
-
Deciphering the vascular labyrinth: role of microRNAs and candidate gene SNPs in brain AVM development - literature review.Neurol Res. 2020 Dec;42(12):1043-1054. doi: 10.1080/01616412.2020.1796380. Epub 2020 Jul 28. Neurol Res. 2020. PMID: 32723034 Review.
-
Novel experimental model of brain arteriovenous malformations using conditional Alk1 gene deletion in transgenic mice.J Neurosurg. 2021 Nov 5:1-12. doi: 10.3171/2021.6.JNS21717. Online ahead of print. J Neurosurg. 2021. PMID: 34740197
-
Gamma Knife surgery for incidental cerebral arteriovenous malformations.J Neurosurg. 2014 Nov;121(5):1015-21. doi: 10.3171/2014.7.JNS131397. Epub 2014 Aug 22. J Neurosurg. 2014. PMID: 25148009
-
Molecular and cellular biology of cerebral arteriovenous malformations: a review of current concepts and future trends in treatment.Neurosurg Focus. 2014 Sep;37(3):E1. doi: 10.3171/2014.7.FOCUS14214. Neurosurg Focus. 2014. PMID: 25175428 Review.
Cited by
-
VEGFR2 Expression Correlates with Postnatal Development of Brain Arteriovenous Malformations in a Mouse Model of Type I Hereditary Hemorrhagic Telangiectasia.Biomedicines. 2023 Nov 27;11(12):3153. doi: 10.3390/biomedicines11123153. Biomedicines. 2023. PMID: 38137374 Free PMC article.
-
Pericytes and vascular smooth muscle cells in central nervous system arteriovenous malformations.Front Physiol. 2023 Aug 4;14:1210563. doi: 10.3389/fphys.2023.1210563. eCollection 2023. Front Physiol. 2023. PMID: 37601628 Free PMC article. Review.
-
An update on preclinical models of hereditary haemorrhagic telangiectasia: Insights into disease mechanisms.Front Med (Lausanne). 2022 Sep 29;9:973964. doi: 10.3389/fmed.2022.973964. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36250069 Free PMC article. Review.
-
A New Chemotactic Mechanism Governs Long-Range Angiogenesis Induced by Patching an Arterial Graft into a Vein.Int J Mol Sci. 2022 Sep 23;23(19):11208. doi: 10.3390/ijms231911208. Int J Mol Sci. 2022. PMID: 36232507 Free PMC article.
-
Cellular loci involved in the development of brain arteriovenous malformations.Front Hum Neurosci. 2022 Sep 21;16:968369. doi: 10.3389/fnhum.2022.968369. eCollection 2022. Front Hum Neurosci. 2022. PMID: 36211120 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
